The global Liver Cancer Therapeutics Market, which stood at USD 2923.58 Million in 2022, is poised for significant growth, projected to surge to USD 12,910.02 Million by 2030, with an impressive Compound Annual Growth Rate (CAGR) of 20.4% during the forecast period of 2023-2030.Liver cancer, one of the most prevalent and lethal malignancies worldwide, presents a critical healthcare...